191 related articles for article (PubMed ID: 34266402)
1. Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
Lang K; Adeberg S; Harrabi S; Held T; Kieser M; Debus J; Herfarth K
BMC Cancer; 2021 Jul; 21(1):812. PubMed ID: 34266402
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
Sulaiman NS; Demizu Y; Koto M; Saitoh JI; Suefuji H; Tsuji H; Ohno T; Shioyama Y; Okimoto T; Daimon T; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):639-646. PubMed ID: 29413278
[TBL] [Abstract][Full Text] [Related]
3. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck.
Takagi M; Demizu Y; Hashimoto N; Mima M; Terashima K; Fujii O; Jin D; Niwa Y; Morimoto K; Akagi T; Daimon T; Sasaki R; Hishikawa Y; Abe M; Murakami M; Fuwa N
Radiother Oncol; 2014 Dec; 113(3):364-70. PubMed ID: 25467004
[TBL] [Abstract][Full Text] [Related]
7. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of adenoid cystic carcinoma of the head and neck in carbon-ion radiotherapy: The impact of histological subtypes.
Ikawa H; Koto M; Takagi R; Ebner DK; Hasegawa A; Naganawa K; Takenouchi T; Nagao T; Nomura T; Shibahara T; Tsuji H; Kamada T
Radiother Oncol; 2017 Jun; 123(3):387-393. PubMed ID: 28528680
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].
Jensen AD; Nikoghosyan A; Hinke A; Debus J; Münter MW
BMC Cancer; 2011 Feb; 11():70. PubMed ID: 21320355
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
[TBL] [Abstract][Full Text] [Related]
12. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
[TBL] [Abstract][Full Text] [Related]
13. Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution.
Högerle BA; Lasitschka F; Muley T; Bougatf N; Herfarth K; Adeberg S; Eichhorn M; Debus J; Winter H; Rieken S; Uhl M
Radiat Oncol; 2019 Jul; 14(1):117. PubMed ID: 31272473
[TBL] [Abstract][Full Text] [Related]
14. Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck.
Shirai K; Saitoh JI; Musha A; Abe T; Kobayashi D; Takahashi T; Tamaki T; Kawamura H; Takayasu Y; Shino M; Toyoda M; Takahashi K; Hirato J; Yokoo S; Chikamatsu K; Ohno T; Nakano T;
Cancer Sci; 2017 Oct; 108(10):2039-2044. PubMed ID: 28730646
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck.
Jensen AD; Debus J
Radiat Oncol; 2019 Nov; 14(1):194. PubMed ID: 31694720
[TBL] [Abstract][Full Text] [Related]
16. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
[TBL] [Abstract][Full Text] [Related]
17. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
18. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Impact of Charged Particle Radiation Therapy for Head and Neck Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis.
Tan M; Chen Y; Du T; Wang Q; Wu X; Zhang Q; Luo H; Liu Z; Sun S; Yang K; Tian J; Wang X
Technol Cancer Res Treat; 2024; 23():15330338241246653. PubMed ID: 38773763
[No Abstract] [Full Text] [Related]
20. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
